Abstract
The Notch signaling plays a key role in cell differentiation, survival, and proliferation through diverse mechanisms. Thus, alterations of the Notch signaling can lead to a variety of disorders including human malignancies. Of considerable interest, recent evidence indicates that there is a significant cross-talk between Notch and microRNAs. As a key component of the Notch-mediated transcription complex, Notch can regulate expression of a number of microRNAs; at the same time, Notch ligands, Notch receptor or Notch effectors are also subject to regulation by microRNAs. Thus, a better understanding of how Notch signaling interacts with microRNAs in the context of cancer will help identify novel biomarkers and therapeutic targets. In this review, we update on recent findings on microRNAs interacting with Notch signaling at various levels, leading to tumorigenesis or chemoresistance. We also highlight the therapeutic potential of targeting Notch signaling and related microRNAs.
Keywords: Notch signaling, microRNAs, tumorigenesis, gene silencing.
Current Drug Targets
Title:Notch-Associated MicroRNAs in Cancer
Volume: 14 Issue: 10
Author(s): Yin-Yuan Mo, Hua Tang and Lucio Miele
Affiliation:
Keywords: Notch signaling, microRNAs, tumorigenesis, gene silencing.
Abstract: The Notch signaling plays a key role in cell differentiation, survival, and proliferation through diverse mechanisms. Thus, alterations of the Notch signaling can lead to a variety of disorders including human malignancies. Of considerable interest, recent evidence indicates that there is a significant cross-talk between Notch and microRNAs. As a key component of the Notch-mediated transcription complex, Notch can regulate expression of a number of microRNAs; at the same time, Notch ligands, Notch receptor or Notch effectors are also subject to regulation by microRNAs. Thus, a better understanding of how Notch signaling interacts with microRNAs in the context of cancer will help identify novel biomarkers and therapeutic targets. In this review, we update on recent findings on microRNAs interacting with Notch signaling at various levels, leading to tumorigenesis or chemoresistance. We also highlight the therapeutic potential of targeting Notch signaling and related microRNAs.
Export Options
About this article
Cite this article as:
Mo Yin-Yuan, Tang Hua and Miele Lucio, Notch-Associated MicroRNAs in Cancer, Current Drug Targets 2013; 14(10) . https://dx.doi.org/10.2174/13894501113149990188
DOI https://dx.doi.org/10.2174/13894501113149990188 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Factors Regulating Human Extravillous Trophoblast Invasion: Chemokine-peptidase and CD9-integrin Systems
Current Pharmaceutical Biotechnology Management of Ovarian Cancer In Younger Women
Reviews on Recent Clinical Trials Drug Targeting Approaches and Use of Drug Delivery Systems in Management of Cancer
Current Pharmaceutical Design Recent Advances in the Development of Casein Kinase 1 Inhibitors
Current Medicinal Chemistry Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems
Current Medicinal Chemistry Modulation of Expression and Activity of ABC Transporters by the Phytoestrogen Genistein. Impact on Drug Disposition
Current Medicinal Chemistry Mitochondrial Toxicity in HAART: An Overview of In Vitro Evidence
Current Pharmaceutical Design Beyond Thymidylate Synthase and Dihydrofolate Reductase: Impact of Non-coding microRNAs in Anticancer Chemoresistance
Current Enzyme Inhibition Hypomethylation and Activation of Syncytin-1 Gene in Endometriotic Tissue
Current Pharmaceutical Design Galanthus nivalis Agglutinin (GNA)-Related Lectins: Traditional Proteins, Burgeoning Drugs?
Current Chemical Biology The Role of Aryl Hydrocarbon Receptor-Regulated Cytochrome P450 Enzymes in Glioma
Current Pharmaceutical Design Targeted Therapies in Breast Cancer: Established Drugs and Recent Developments
Current Clinical Pharmacology Targeting the Folate Receptor: Improving Efficacy in Inorganic Medicinal Chemistry
Current Medicinal Chemistry Negative Glucocorticoid Receptor Response Elements and their Role in Glucocorticoid Action
Current Pharmaceutical Design Testicular Germ Cell Tumors: A Paradigm for the Successful Treatment of Solid Tumor Stem Cells
Current Cancer Therapy Reviews Melatonin in Pregnancy: Effects on Brain Development and CNS Programming Disorders
Current Pharmaceutical Design The Ligand Binding Region of the Sigma-1 Receptor: Studies Utilizing Photoaffinity Probes, Sphingosine and N-Alkylamines
Current Pharmaceutical Design Serotonin as a Modulator of Immune Function: An Overview
Current Immunology Reviews (Discontinued) Recent Advances in Carbon Nanotubes as Delivery Systems for Anticancer Drugs
Current Medicinal Chemistry Emulsomes Meet S-layer Proteins: An Emerging Targeted Drug Delivery System
Current Pharmaceutical Biotechnology